参考文献/References:
[1] Wang W,Jiang B,Sun H,et al.Prevalence, incidence, and mortality of stroke in China: results from a nationwide Population-Based survey of 480 687 adults[J].Circulation,2017,135(8):759-771.
[2] Bruzzone R,Hormuzdi SG,Barbe MT,et al.Pannexins, a family of gap junction proteins expressed in brain[J].Proc Natl Acad Sci U S A,2003,100(23):13644-13649.
[3] Laird DW.Life cycle of connexins in health and disease[J].Biochem J,2006,394(Pt 3):527-543.
[4] Macvicar BA,Thompson RJ.Non-junction functions of pannexin-1 channels[J].Trends Neurosci,2010,33(2):93-102.
[5] Esseltine JL,Laird DW.Next-Generation connexin and pannexin cell biology[J].Trends Cell Biol,2016,26(12):944-955.
[6] Panchin Y,Kelmanson I,Matz M,et al.A ubiquitous family of putative gap junction molecules[J].Current Biology,2000,10(13):R473-R474.
[7] Altschul SF,Madden TL,Schäffer AA,et al.Gapped BLAST and PSI-BLAST: a new Generation of protein database search programs[J].Nucleic Acids Res,1997,25(17):3389-3402.
[8] Bao L,Locovei S,Dahl G.Pannexin membrane channels are mechanosensitive conduits for ATP[J].FEBS Lett,2004,572(1/3):65-68.
[9] Locovei S,Bao L,Dahl G.Pannexin 1 in erythrocytes: function without a gap[J].Proc Natl Acad Sci U S A,2006,103(20):7655-7659.
[10] Boassa D,Qiu F,Dahl G,et al.Trafficking dynamics of glycosylated pannexin 1 proteins[J].Cell Commun Adhes,2008,15(1):119-132.
[11] Ransford GA,Fregien N,Qiu F,et al.Pannexin 1 contributes to ATP release in airway epithelia[J].Am J Respir Cell Mol Biol,2009,41(5):525-534.
[12] Li S,Bjelobaba I,Stojilkovic SS.Interactions of pannexin1 channels with purinergic and NMDA receptor channels[J].Biochimica et Biophysica Acta-Biomembranes,2018,1860(1):166-173.
[13] Dahl G,Keane RW.Pannexin: from discovery to bedside in 11±4 years?[J].Brain Research,2012,1487:150-159.
[14] Penuela S,Bhalla R,Nag K,et al.Glycosylation regulates pannexin intermixing and cellular localization[J].Mol Biol Cell,2009,20(20):4313-4323.
[15] Arbeloa J,Pérez-Samartín A,Gottlieb M,et al.P2X7 receptor blockade prevents ATP excitotoxicity in neurons and reduces brain damage after ischemia[J].Neurobiol Dis,2012,45(3):954-961.
[16] Cisneros-Mejorado A,Gottlieb M,Cavaliere F,et al.Blockade of P2X7 receptors or pannexin-1 channels similarly attenuates postischemic damage[J].J Cereb Blood Flow Metab,2015,35(5):843-850.
[17] Cull-Candy S,Brickley S,Farrant M.NMDA receptor subunits: diversity, development and disease[J].Curr Opin Neurobiol,2001,11(3):327-335.
[18] Weilinger NL,Tang PL,Thompson RJ.Anoxia-induced NMDA receptor activation opens pannexin channels via Src family kinases[J].J Neurosci,2012,32(36):12579-12588.
[19] Ikonomidou C,Turski L.Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?[J].The Lancet Neurology,2002,1(6):383-386.
[20] Weilinger NL,Lohman AW,Rakai BD,et al.Metabotropic NMDA receptor signaling couples Src family kinases to pannexin-1 during excitotoxicity[J].Nat Neurosci,2016,19(3):432-442.
[21] 符师宁,胡丹辰,闫军浩.水通道蛋白4在脑缺血后脑水肿中的作用[J].生理科学进展,2016,47(5):361-364.
[22] Jian Z,Ding S,Deng H,et al.Probenecid protects against oxygen-glucose deprivation injury in primary astrocytes by regulating inflammasome activity[J].Brain Res,2016,1643:123-129.
[23] Sandilos JK,Chiu YH,Chekeni FB,et al.Pannexin 1, an ATP release Channel, is activated by caspase cleavage of its pore-associated C-terminal autoinhibitory region[J].J Biol Chem,2012,287(14):11303-11311.
[24] Bravo D,Maturana CJ,Pelissier T,et al.Interactions of pannexin 1 with NMDA and P2X7 receptors in central nervous system pathologies: Possible role on chronic pain[J].Pharmacological Research,2015,101:86-93.
[25] Dahl G.ATP release through pannexon channels[J].Philos Trans R Soc Lond B Biol Sci,2015,370(1672):20140191.
[26] Scemes E,Velíková J.Exciting and not so exciting roles of pannexins[J].Neuroscience Letters,2019,695:25-31.
[27] Chekeni FB,Elliott MR,Sandilos JK,et al.Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis[J].Nature,2010,467(7317):863-867.
[28] Pelegrin P,Surprenant A.Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor[J].EMBO J,2006,25(21):5071-5082.
[29] Wang J,Ambrosi C,Qiu F,et al.The membrane protein Pannexin1 forms two open-channel conformations depending on the mode of activation[J].Sci Signal,2014,7(335):ra69.
[30] Yang DH,He Y,Munoz-Planillo R,et al.Caspase-11 requires the pannexin-1 Channel and the purinergic P2X7 pore to mediate pyroptosis and endotoxic shock[J].Immunity,2015,43(5):923-932.
[31] Qiu F,Dahl G.A permeant regulating its permeation pore: inhibition of pannexin 1 channels by ATP[J].Am J Physiol Cell Physiol,2009,296(2):C250-C255.
[32] Surprenant A,Rassendren F,Kawashima E,et al.The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor(P2X7)[J].Science,1996,272(5262):735-738.
[33] Dossi E,Blauwblomme T,Moulard J,et al.Pannexin-1 channels contribute to seizure Generation in human epileptic brain tissue and in a mouse model of epilepsy[J].Sci Transl Med,2018,10(443):eaar3796.
[34] Schneider KS,Groß CJ,Dreier RF,et al.The inflammasome drives GSDMD-Independent secondary pyroptosis and IL-1 release in the absence of caspase-1 protease activity[J].Cell Rep,2017,21(13):3846-3859.
[35] Chen KW,Demarco B,Heilig R,et al.Extrinsic and intrinsic apoptosis activate pannexin-1 to drive NLRP3 inflammasome assembly[J].EMBO J,2019,38(10):e101638.
[36] Karmakar M,Katsnelson MA,Dubyak GR,et al.Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP[J].Nat Commun,2016,7:10555.
[37] Chen KW,Demarco B,Broz P.Pannexin-1 promotes NLRP3 activation during apoptosis but is dispensable for canonical or noncanonical inflammasome activation[J].Eur J Immunol,2020,50(2):170-177.
[38] Davidson JS,Baumgarten IM,Harley EH.Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid[J].Biochem Biophys Res Commun,1986,134(1):29-36.
[39] Bruzzone R,Barbe MT,Jakob NJ,et al.Pharmacological properties of homomeric and heteromeric pannexin hemichannels expressed in Xenopus oocytes[J].J Neurochem,2005,92(5):1033-1043.
[40] Silverman W,Locovei S,Probenecid DG,et al.Inhibits pannexin 1 channels[J].Am J Physiol Cell Physiol,2008,295(3):C761-C767.
[41] Freeman TJ,Sayedyahossein S,Johnston D,et al.Inhibition of pannexin 1 reduces the tumorigenic properties of human melanoma cells[J].Cancers(Basel),2019,11(1):102.
[42] Poon IK,Chiu YH,Armstrong AJ,et al.Unexpected Link between an antibiotic, pannexin channels and apoptosis[J].Nature,2014,507(7492):329-334.
[43] Garg C,Seo JH,Ramachandran J,et al.Trovafloxacin attenuates neuroinflammation and improves outcome after traumatic brain injury in mice[J].J Neuroinflammation,2018,15(1):42.
[44] Liu HH.Safety profile of the fluoroquinolones: focus on levofloxacin[J].Drug Safety,2010,33(5):353-369.
[45] Giustarini G,Vrisekoop N,Kruijssen L,et al.Trovafloxacin-Induced liver injury: lack in regulation of inflammation by inhibition of nucleotide release and neutrophil movement[J].Toxicol Sci,2019,167(2):385-396.
[46] Good ME,Chiu YH,Poon IKH,et al.Pannexin 1 channels as an unexpected new target of the Anti-Hypertensive drug spironolactone[J].Circ Res,2018,122(4):606-615.